New York S 2000: Relates to mandatory health insurance coverage for follow-up screening or diagnostic services for lung cancer

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 - This bill is not active in this session.

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S02000 Summary:

BILL NOS02000A

&nbsp

SAME ASSAME AS A01195-A

&nbsp

SPONSORADDABBO

&nbsp

COSPNSRCLEARE, COMRIE, COONEY, HARCKHAM, PARKER, SALAZAR, SKOUFIS

&nbsp

MLTSPNSR

&nbsp

Amd §§3216, 3221 & 4303, Ins L

&nbsp

Requires that health insurance policies shall provide coverage for follow-up screening or diagnostic services for lung cancer; provides that no patient cost sharing shall be imposed for follow-up screening or diagnostic services for lung cancer.

Go to top S02000 Actions:

BILL NOS02000A

&nbsp

01/14/2025REFERRED TO INSURANCE

02/03/20251ST REPORT CAL.235

02/04/20252ND REPORT CAL.

02/05/2025ADVANCED TO THIRD READING 

03/18/2025PASSED SENATE

03/18/2025DELIVERED TO ASSEMBLY

03/18/2025referred to insurance

05/19/2025RECALLED FROM ASSEMBLY

05/19/2025returned to senate

05/19/2025VOTE RECONSIDERED - RESTORED TO THIRD READING

05/19/2025AMENDED ON THIRD READING (T) 2000A

05/29/2025SUBSTITUTED BY A1195A

&nbspA01195 AMEND=A Peoples-Stokes

&nbsp01/09/2025referred to insurance

&nbsp05/16/2025amend (t) and recommit to insurance

&nbsp05/16/2025print number 1195a

&nbsp05/20/2025reported referred to rules

&nbsp05/21/2025reported 

&nbsp05/21/2025rules report cal.201

&nbsp05/21/2025ordered to third reading rules cal.201

&nbsp05/21/2025passed assembly

&nbsp05/21/2025delivered to senate

&nbsp05/21/2025REFERRED TO INSURANCE

&nbsp05/29/2025SUBSTITUTED FOR S2000A

&nbsp05/29/20253RD READING CAL.235

&nbsp05/29/2025PASSED SENATE

&nbsp05/29/2025RETURNED TO ASSEMBLY

&nbsp12/01/2025delivered to governor

&nbsp12/04/2025signed chap.576

Go to topS02000 Committee&nbspVotes:

Go to topS02000 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS02000 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 2000--A
 Cal. No. 235

 2025-2026 Regular Sessions

 IN SENATE

 January 14, 2025
 ___________

 Introduced by Sens. ADDABBO, CLEARE, COMRIE, COONEY, HARCKHAM, PARKER,
 SALAZAR, SKOUFIS -- read twice and ordered printed, and when printed
 to be committed to the Committee on Insurance -- reported favorably
 from said committee, ordered to first and second report, ordered to a
 third reading, passed by Senate and delivered to the Assembly,
 recalled, vote reconsidered, restored to third reading, amended and
 ordered reprinted, retaining its place in the order of third reading

 AN ACT to amend the insurance law, in relation to mandatory health
 insurance coverage for follow-up screening or diagnostic services for
 lung cancer

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Subsection (i) of section 3216 of the insurance law is
 2 amended by adding a new paragraph 41 to read as follows:
 3 (41) (A) Every policy which provides medical, major medical, or simi-
 4 lar comprehensive-type coverage shall provide coverage for follow-up
 5 screening or diagnostic services for lung cancer upon the recommendation
 6 of a health care provider acting within the provider's scope of practice
 7 pursuant to title eight of the education law, and as recommended by
 8 nationally recognized clinical practice guidelines for the detection of
 9 lung cancer.
 10 (B) Notwithstanding any other provision of law, any policy that
 11 provides coverage required by this paragraph shall not impose patient
 12 cost sharing for follow-up screening or diagnostic services for lung
 13 cancer.
 14 (C) For the purposes of this paragraph, "nationally recognized clin-
 15 ical practice guidelines" means evidence-based, peer reviewed clinical
 16 practice guidelines informed by a systematic review of evidence and an
 17 assessment of the benefits, and risks of alternative care options
 18 intended to optimize patient care developed by independent organizations

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD02876-03-5

 S. 2000--A 2

 1 or medical professional societies utilizing a transparent methodology
 2 and reporting structure and with a conflict of interest policy.
 3 (D) Nothing in this paragraph shall be construed to prevent medical
 4 management or utilization review of the services, including preauthori-
 5 zation,